At Ace Therapeutics, we understand the unique challenges associated with developing novel candidate drugs for gastrointestinal diseases. We offer customized preclinical services to support your research and development needs, including the development and validation of disease models, in vitro pharmacodynamic platforms, and in vivo efficacy and safety studies. Our specialized expertise also includes conducting biomarker detection, pharmacokinetic evaluations, toxicology assessments and analytical method development.
We offer best-in-class biophysical technologies such as ASMS, Intact-MS, Native-MS, HDX-MS, TSA, SPR, supporting biologic drug discovery from target ID and validation to screening and structure-based design.
Combining medicinal chemistry, synthesis, analytics and computational capabilities, we provide integrated small molecule discovery solutions from virtual screening to purification.
Leveraging our protein production and structural expertise, we enable all aspects of PROTAC/molecular glue R&D from protein co-crystallization to screening, kinetics analysis, metabolism profiling, and compound optimization.
Through our proprietary XDC platform integrating antibody, peptide and small molecule conjugation know-how, we offer comprehensive integrated conjugated drug development from design to functional assessment.
Ace Therapeutics is a leading provider of specialized preclinical contract research services to support the development of novel therapeutics in gastroenterology. Our expert team specializes in conducting a comprehensive range of studies related to gastrointestinal diseases such as inflammation, motility disorders, cancer and more. We offer customized solutions for all stages of drug discovery and development. Contact us today to discuss your unique research needs and timelines.
Our products and services are for research use only and can not be used for diagnostic or other purposes.